Prediction and Prevention of Late Pregnancy Accidents in Diabetes

White, Priscilla; Titus, R. S.; Joslin, Elliott P.; Hunt, Hazel M.

doi:10.1097/00000441-193910000-00005

The American Journal of the Medical Sciences

1939

DOI: 10.1097/00000441-193910000-00005

|View full text |Cite

Prediction and Prevention of Late Pregnancy Accidents in Diabetes

Priscilla White¹,

R. S. Titus²,

Elliott P. Joslin³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1941

1998

Publication Types

Select...

Article6

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 44 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2 Insulin therapy allowed women with complicated diabetes to conceive, but the therapeutic modalities available were not able to overcome complications related to vascular compromise. 3 Women with diabetes are living longer and therefore, more women with microvascular disease are becoming pregnant. In the past, diabetic women with vascular complications were counseled to avoid pregnancy or terminate pregnancy if it occurred.…”

mentioning

confidence: 99%

Pregnancy Outcomes Among Women with and Without Diabetic Microvascular Disease (White's Classes B To FR) Versus Non-Diabetic Controls

et al. 1998

View full text Add to dashboard Cite

The objective of this paper is to evaluate the impact of contemporary management on the maternal and neonatal outcomes of pregnancies complicated by diabetes in women with microvascular disease versus women without microvascular disease. The study population consisted of two hundred and eighty-eight (288) pregnant women with pregestational diabetes and one hundred and fifty (150) healthy pregnant controls. Diabetic women were grouped according to the presence (n = 103) or absence of diabetic microvascular disease (n = 185). Data were collected regarding diabetes management, level of glycemic control, and the development of antenatal complications. Maternal and neonatal outcomes were compared among the three groups. Women in the diabetes groups were stratified according to mean blood glucose levels and glycosylated hemoglobin during each trimester. There was no significant difference found between the two diabetes groups in terms of preterm labor, polyhydramnios, pyelonephritis, and growth restriction. The only maternal complications that occurred with increased incidence among women with microvascular disease were acute hypertensive complications (51.6 vs. 32.9%; p<0.05). However, when the diabetes groups were compared to healthy controls, a significant difference was seen in all maternal and neonatal complications. Preterm delivery, polyhydramnios, and large-for-gestational-age (LGA) infants were associated with poor third-trimester metabolic control as compared with others in satisfactory metabolic controls: 30.8 vs. 11.4% for preterm delivery; 17.3 vs. 5.1% for polyhydramnios; 51.9 vs. 33.9% for LGA; p<0.05. Congenital malformations were associated with poor first-trimester glucose control (5.8 vs. 1.3% anomalies in well-controlled women). Furthermore, major congenital malformations were also significantly increased in the offspring of women with diabetic microvascular disease 6.8%, as compared to 1.69% in diabetic women without microvascular disease; p<0.01. The incidence of hypertensive complications did not differ between the two diabetic groups. Pregestational diabetic women with and without microvascular disease can be counseled to anticipate comparably favorable pregnancy outcomes, although maternal and neonatal complications may exceed that experienced by pregnant women without diabetes mellitus.

show abstract

mentioning

confidence: 99%

Pregnancy Outcomes Among Women with and Without Diabetic Microvascular Disease (White's Classes B To FR) Versus Non-Diabetic Controls

et al. 1998

View full text Add to dashboard Cite

show abstract

Progesterone Therapy in Dermatoses of Pregnancy (Herpes Gestationis)

Keaty¹

1951

Arch Dermatol

View full text Add to dashboard Cite

Metabolism and Diabetes

Rynearson¹

1941

Arch Intern Med (Chic)

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Prediction and Prevention of Late Pregnancy Accidents in Diabetes

Cited by 44 publications

References 0 publications

Pregnancy Outcomes Among Women with and Without Diabetic Microvascular Disease (White's Classes B To FR) Versus Non-Diabetic Controls

Pregnancy Outcomes Among Women with and Without Diabetic Microvascular Disease (White's Classes B To FR) Versus Non-Diabetic Controls

Progesterone Therapy in Dermatoses of Pregnancy (Herpes Gestationis)

Metabolism and Diabetes

Contact Info

Product

Resources

About